Zydus Cadila gets USFDA nod for Commercialisation Generic Schizophrenia drug Cariprazine
Synopsis – The company’s subsidiary has received tentative approval from the US Food and Drug Administration (USFDA) for Cariprazine capsules in the…
Synopsis – The company’s subsidiary has received tentative approval from the US Food and Drug Administration (USFDA) for Cariprazine capsules in the…
Summary – French health authorities have approved the use of an antibody treatment made by AstraZeneca for high-risk people who show resistance…
Summary – Lupin Diagnostics, a 100 percent subsidiary of Lupin Limited, has set up a state-of-the-art 45,000 sq. ft National Reference Laboratory…
Synopsis – England’s National Institute for Health and Care Excellence (NICE) has given a thumbs up to Sobi’s paroxysmal nocturnal hemoglobinuria (PNH)…
Summary : With the FDA’s emergency use authorization today of AstraZeneca’s long-acting antibody cocktail, the roughly 2% of U.S. residents who are…
Summary : The company also said studies are underway to provide information on the impact of the new Omicron variant on Evusheld,…
Synopsis: Under the terms of this agreement, Tabuk Pharmaceuticals will hold the marketing authorisation for select speciality products of Biocon and be…
Summary – U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application to evaluate NUV-422. It is a…
Summary : Alembic said it has so far received 15 product approvals this year. Alembic Pharma received approval from the US health…
Summary – Pfizer says the protection provided by two doses of its anti-COVID-19 vaccine against previous strains will match that provided by…